{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:16:37Z","timestamp":1774908997036,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejim.2020.04.006","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T07:29:57Z","timestamp":1587022197000},"page":"58-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Serial investigation of Angiotensin-Converting Enzyme in sarcoidosis patients treated with Angiotensin-Converting Enzyme Inhibitor"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-5722","authenticated-orcid":false,"given":"Miriana","family":"d'Alessandro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bergantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Cameli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Cameli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje","family":"Prasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Plataroti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piersante","family":"Sestini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Bargagli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2020.04.006_bib0001","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1034\/j.1399-3003.1999.14d02.x","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders","volume":"14","author":"Costabel","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2020.04.006_bib0002","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCP.0000000000000499","article-title":"Why do people die from pulmonary sarcoidosis","volume":"24","author":"Kouranos","year":"2018","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ejim.2020.04.006_bib0003","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/BOR.0000000000000489","article-title":"Current management of sarcoidosis I: pulmonary, cardiac, and neurologic manifestations","volume":"30","author":"West","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ejim.2020.04.006_bib0004","article-title":"BAL biomarkers' panel for differential diagnosis of interstitial lung diseases","author":"d'Alessandro","year":"2020","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.ejim.2020.04.006_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8565423","article-title":"Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6","volume":"2019","author":"Bergantini","year":"2019","journal-title":"Dis Markers"},{"key":"10.1016\/j.ejim.2020.04.006_bib0006","first-page":"1","article-title":"The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients","author":"Cameli","year":"2020","journal-title":"Respiration"},{"key":"10.1016\/j.ejim.2020.04.006_bib0007","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10238-019-00578-3","article-title":"NK and NKT-like cells in granulomatous and fibrotic lung diseases","volume":"19","author":"Bergantini","year":"2019","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.ejim.2020.04.006_bib0008","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jprot.2015.08.012","article-title":"A functional proteomics approach to the comprehension of sarcoidosis","volume":"128","author":"Landi","year":"2015","journal-title":"J Proteomics"},{"key":"10.1016\/j.ejim.2020.04.006_bib0009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000505653","article-title":"The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients","volume":"99","author":"Cameli","year":"2020","journal-title":"Respiration"},{"key":"10.1016\/j.ejim.2020.04.006_bib0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1357-2725(02)00309-6","article-title":"The angiotensin converting enzyme (ACE)","volume":"35","author":"Coates","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ejim.2020.04.006_bib0011","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00408-015-9826-3","article-title":"Diagnostic Utility of Angiotensin-Converting Enzyme in Sarcoidosis: A Population-Based Study","volume":"194","author":"Ungprasert","year":"2016","journal-title":"Lung"},{"key":"10.1016\/j.ejim.2020.04.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012205","article-title":"Relationship between CT activity score with lung function and the serum angiotensin converting enzyme in pulmonary sarcoidosis on chest HRCT","volume":"97","author":"Duan","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejim.2020.04.006_bib0013","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-3476(81)80959-6","article-title":"Serum angiotensin-converting enzyme activity in normal children and in those with sarcoidosis","volume":"99","author":"Rodriguez","year":"1981","journal-title":"J Pediatr"},{"key":"10.1016\/j.ejim.2020.04.006_bib0014","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/10408369109106868","article-title":"Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids","volume":"28","author":"Beneteau-Burnat","year":"1991","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.ejim.2020.04.006_bib0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJM198008143030716","article-title":"The measurement of angiotensin-converting enzyme in subjects receiving captopril","volume":"303","author":"Roulston","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2020.04.006_bib0016","first-page":"118","article-title":"Effect of captopril and enalapril medication on the serum ACE test for sarcoidosis","volume":"6","author":"Lieberman","year":"1989","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.ejim.2020.04.006_bib0017","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation","volume":"2","author":"Scadding","year":"1961","journal-title":"Br Med J"},{"key":"10.1016\/j.ejim.2020.04.006_bib0018","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2020.04.006_bib0019","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1183\/09031936.05.00034905","article-title":"Standardisation of the single-breath determination of carbon monoxide uptake in the lung","volume":"26","author":"Macintyre","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2020.04.006_bib0020","first-page":"1","article-title":"Standardized lung function testing. Official statement of the European Respiratory Society","volume":"16","year":"1993","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.ejim.2020.04.006_bib0021","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1373\/49.9.1510","article-title":"Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis","volume":"49","author":"Rothkrantz-Kos","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejim.2020.04.006_bib0022","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/2040622318790197","article-title":"Epidemiology of sarcoidosis: current findings and future directions","volume":"9","author":"Arkema","year":"2018","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.ejim.2020.04.006_bib0023","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1378\/chest.98.6.1538b","article-title":"Effect of converting enzyme inhibitors on serum ACE test","volume":"98","author":"Lieberman","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2020.04.006_bib0024","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1378\/chest.15-1061","article-title":"Ordering of the Serum Angiotensin-Converting Enzyme Test in Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy: An Avoidable but Common Error","volume":"148","author":"Krasowski","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2020.04.006_bib0025","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.ejim.2018.09.018","article-title":"Appropriateness of ordering serum angiotensin-converting enzyme during renin-angiotensin-aldosterone system inhibitor therapy","volume":"59","author":"Betrains","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2020.04.006_bib0026","first-page":"380","article-title":"Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences","volume":"34","author":"Brito-Zeron","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2020.04.006_bib0027","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01290-2016","article-title":"Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013","volume":"49","author":"Ungprasert","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2020.04.006_bib0028","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000477736","article-title":"Increased Risk of Atherosclerosis in Patients with Sarcoidosis","volume":"84","author":"Bargagli","year":"2017","journal-title":"Pathobiology"},{"key":"10.1016\/j.ejim.2020.04.006_bib0029","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.amjcard.2017.05.060","article-title":"Reliability of Cardiovascular Risk Calculators to Estimate Accurately the Risk of Cardiovascular Disease in Patients With Sarcoidosis","volume":"120","author":"Ungprasert","year":"2017","journal-title":"Am J Cardiol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520301217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520301217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:31:06Z","timestamp":1760607066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620520301217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":29,"alternative-id":["S0953620520301217"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2020.04.006","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serial investigation of Angiotensin-Converting Enzyme in sarcoidosis patients treated with Angiotensin-Converting Enzyme Inhibitor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2020.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}